5/3/2013 6:33:22 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SEATTLE, May 2, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported financial results for the first quarter ended March 31, 2013.
"In the first quarter, we generated initial commercial sales of PIXUVRI® in countries in the European Union where there is market access pending the completion of the reimbursement process," said James Bianco, M.D., President and CEO of CTI.
Help employers find you! Check out all the jobs and post your resume.
comments powered by